United Kingdom

ChemoCentryx Inc (CCXI.OQ)

CCXI.OQ on NASDAQ Stock Exchange Global Select Market

2:39pm GMT
Change (% chg)

$0.15 (+1.23%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Thomas Schall

58 2012 Chairman of the Board, President, Chief Executive Officer

Susan Kanaya

55 2017 Chief Financial Officer, Executive Vice President, Chief Administrative Officer, Secretary, IR Contact Officer

Jan Hillson

65 2016 Senior Vice President - Drug Development

Rajinder Singh

51 2016 Senior Vice President - Research

Markus Cappel

57 2007 Chief Business Officer, Treasurer